🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to demonstrate the effectiveness and tolerab...
Status
Terminated
Location
Parkway Medical Center
Start Date
2004-04
Trial ID
NCT00312221
Treatments Being Tested
This study will determine whether selective serotonin reuptake inhibitors (...
Status
Unknown
Location
Multiple Locations
Start Date
2023-03-15
Trial ID
NCT05730062
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Cebrano...
Status
Completed
Location
ALLEVIATE 2 Site 001108
Start Date
2024-07-18
Trial ID
NCT06423703
Treatments Being Tested
Evaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxyc...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT00986180
Treatments Being Tested
Tapentadol is FDA approved for the treatment of moderate to severe acute pa...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2011-05
Trial ID
NCT01500317
Treatments Being Tested
The purpose of this study is to compare the risk of shopping behavior of ta...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01545778
Treatments Being Tested
The trial comprises an Enrollment Visit, a Qualification Phase, a Treatment...
Status
Completed
Location
Algorithme Pharma
Start Date
2018-07-24
Trial ID
NCT03765346
The study will evaluate the human abuse liability of PTI-821 (oxycodone ext...
Status
Completed
Location
PRA-EDS
Start Date
2017-05-15
Trial ID
NCT03475862
Treatments Being Tested
This is a Phase 3, two-arm, double-blind study of efficacy and safety of Q8...
Status
Completed
Location
Investigator Site
Start Date
2010-02
Trial ID
NCT01055015
The primary aim of this study is to determine if chronic pain subjects on a...
Status
Completed
Location
Vince and Associates Clinical Research, Inc.
Start Date
2013-06
Trial ID
NCT01871285
Treatments Being Tested